Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata [Phase 3]

View source ↗

Summary

This update covers the extension Phase 3 trial of Jaktinib in adults with Alopecia Areata, evaluating safety and efficacy. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Jaktinib (jaktinib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Alopecia Areata | Phase 3 | Status: COMPLETED